|
MOBKL2B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.7328999998082E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.48919998554931E-09 |
| Normal-vs-Stage2 |
4.360400E-02 |
| Normal-vs-Stage3 |
1.016570E-01 |
| Normal-vs-Stage4 |
9.185000E-01 |
| Stage1-vs-Stage2 |
3.990000E-01 |
| Stage1-vs-Stage3 |
1.642120E-02 |
| Stage1-vs-Stage4 |
1.576790E-04 |
| Stage2-vs-Stage3 |
4.214000E-01 |
| Stage2-vs-Stage4 |
6.407900E-02 |
| Stage3-vs-Stage4 |
1.701410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.0102999999928E-06 |
| Normal-vs-AfricanAmerican |
4.382600E-01 |
| Normal-vs-Asian |
2.709400E-01 |
| Caucasian-vs-AfricanAmerican |
6.144200E-02 |
| Caucasian-vs-Asian |
6.217200E-01 |
| AfricanAmerican-vs-Asian |
2.080600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.158300E-03 |
| Normal-vs-Female |
5.61090000017472E-08 |
| Male-vs-Female |
1.200800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.840600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.71080999999962E-05 |
| Normal-vs-Age(61-80Yrs) |
4.636900E-04 |
| Normal-vs-Age(81-100Yrs) |
1.336760E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.629900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.529620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.621400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.455800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.086400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.795000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.534200E-02 |
| Normal-vs-Grade 2 |
4.95499996588933E-09 |
| Normal-vs-Grade 3 |
3.161400E-04 |
| Normal-vs-Grade 4 |
1.050360E-02 |
| Grade 1-vs-Grade 2 |
9.744800E-01 |
| Grade 1-vs-Grade 3 |
4.267800E-01 |
| Grade 1-vs-Grade 4 |
2.280300E-03 |
| Grade 2-vs-Grade 3 |
4.135900E-02 |
| Grade 2-vs-Grade 4 |
5.57250023902611E-10 |
| Grade 3-vs-Grade 4 |
1.56664999999556E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
3.625000E-01 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.45620000000057E-05 |
| Normal-vs-N1 |
5.714000E-01 |
| N0-vs-N1 |
1.020420E-01 |
|
|
